Development of Computational In Silico Model for Nano Lipid Carrier Formulation of Curcumin

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2023 Feb 25

PMID 36838817

Authors

Omar Waleed Abduljaleel Albasri

Palanirajan Vijayaraj Kumar

Mogana Sundari Rajagopal

Affiliations

Soon will be listed here.

Abstract

The oral delivery system is very important and plays a significant role in increasing the solubility of drugs, which eventually will increase their absorption by the digestive system and enhance the drug bioactivity. This study was conducted to synthesize a novel curcumin nano lipid carrier (NLC) and use it as a drug carrier with the help of computational molecular docking to investigate its solubility in different solid and liquid lipids to choose the optimum lipids candidate for the NLCs formulation and avoid the ordinary methods that consume more time, materials, cost, and efforts during laboratory experiments. The antiviral activity of the formed curcumin-NLC against SARS-CoV-2 (COVID-19) was assessed through a molecular docking study of curcumin's affinity towards the host cell receptors. The novel curcumin drug carrier was synthesized as NLC using a hot and high-pressure homogenization method. Twenty different compositions of the drug carrier (curcumin nano lipid) were synthesized and characterized using different physicochemical techniques such as UV-Vis, FTIR, DSC, XRD, particle size, the zeta potential, and AFM. The in vitro and ex vivo studies were also conducted to test the solubility and the permeability of the 20 curcumin-NLC formulations. The NLC as a drug carrier shows an enormous enhancement in the solubility and permeability of the drug.

References

Semple S, Leone R, Barbosa C, Tam Y, Lin P . Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics. Pharmaceutics. 2022; 14(2). PMC: 8876479. DOI: 10.3390/pharmaceutics14020398. View

Rubab S, Naeem K, Rana I, Khan N, Afridi M, Ullah I . Enhanced neuroprotective and antidepressant activity of curcumin-loaded nanostructured lipid carriers in lipopolysaccharide-induced depression and anxiety rat model. Int J Pharm. 2021; 603:120670. DOI: 10.1016/j.ijpharm.2021.120670. View

Ahmad Khan K, Khan G, Muzammal M, Al Mohaini M, Alsalman A, Al Hawaj M . Preparation of Losartan Potassium Controlled Release Matrices and In-Vitro Investigation Using Rate Controlling Agents. Molecules. 2022; 27(3). PMC: 8839457. DOI: 10.3390/molecules27030864. View

Rahamathulla M, Saisivam S, Alshetaili A, Hani U, Gangadharappa H, Alshehri S . Design and Evaluation of Losartan Potassium Effervescent Floating Matrix Tablets: In Vivo X-ray Imaging and Pharmacokinetic Studies in Albino Rabbits. Polymers (Basel). 2021; 13(20). PMC: 8538939. DOI: 10.3390/polym13203476. View

Tee Y, Kumar P, Maki M, Elumalai M, Rahman S, Cheah S . Mucoadhesive Low Molecular Chitosan Complexes to Protect rHuKGF from Proteolysis: Characterization and FHs 74 Int Cell Proliferation Studies. Curr Pharm Biotechnol. 2020; 22(7):969-982. DOI: 10.2174/1389201021666201218124450. View

Ganassin R, Mello da Silva V, Araujo V, Tavares G, da Silva P, Caceres-Velez P . Solid lipid nanoparticles loaded with curcumin: development and toxicity against CT26 cells. Nanomedicine (Lond). 2022; 17(3):167-179. DOI: 10.2217/nnm-2021-0229. View

Selvaraj K, Yoo B . Curcumin-Loaded Nanostructured Lipid Carrier Modified with Partially Hydrolyzed Ginsenoside. AAPS PharmSciTech. 2019; 20(6):252. DOI: 10.1208/s12249-019-1467-z. View

Wang F, Chen J, Dai W, He Z, Zhai D, Chen W . Pharmacokinetic studies and anticancer activity of curcumin-loaded nanostructured lipid carriers. Acta Pharm. 2017; 67(3):357-371. DOI: 10.1515/acph-2017-0021. View

Zhong Q, Zhang L . Nanoparticles fabricated from bulk solid lipids: Preparation, properties, and potential food applications. Adv Colloid Interface Sci. 2019; 273:102033. DOI: 10.1016/j.cis.2019.102033. View

10.

Sakellari G, Zafeiri I, Batchelor H, Spyropoulos F . Formulation design, production and characterisation of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for the encapsulation of a model hydrophobic active. Food Hydrocoll Health. 2022; 1:None. PMC: 8721956. DOI: 10.1016/j.fhfh.2021.100024. View

11.

Garg N, Sharma G, Singh B, Nirbhavane P, Tyagi R, Shukla R . Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s). Int J Pharm. 2016; 517(1-2):413-431. DOI: 10.1016/j.ijpharm.2016.12.010. View

12.

Hoang Thi T, Suys E, Lee J, Nguyen D, Park K, Truong N . Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines. Vaccines (Basel). 2021; 9(4). PMC: 8069344. DOI: 10.3390/vaccines9040359. View

13.

Obergrussberger A, Friis S, Bruggemann A, Fertig N . Automated patch clamp in drug discovery: major breakthroughs and innovation in the last decade. Expert Opin Drug Discov. 2020; 16(1):1-5. DOI: 10.1080/17460441.2020.1791079. View

14.

Kinzhalov M, Kashina M, Mikherdov A, Mozheeva E, Novikov A, Smirnov A . Dramatically Enhanced Solubility of Halide-Containing Organometallic Species in Diiodomethane: The Role of Solvent⋅⋅⋅Complex Halogen Bonding. Angew Chem Int Ed Engl. 2018; 57(39):12785-12789. DOI: 10.1002/anie.201807642. View

15.

Sabanes Zariquiey F, Jacoby E, Vos A, van Vlijmen H, Tresadern G, Harvey J . Divide and Conquer. Pocket-Opening Mixed-Solvent Simulations in the Perspective of Docking Virtual Screening Applications for Drug Discovery. J Chem Inf Model. 2022; 62(3):533-543. DOI: 10.1021/acs.jcim.1c01164. View

16.

Wang G, Li R, Parseh B, Du G . Prospects and challenges of anticancer agents' delivery via chitosan-based drug carriers to combat breast cancer: a review. Carbohydr Polym. 2021; 268:118192. DOI: 10.1016/j.carbpol.2021.118192. View

17.

Nakmode D, Bhavana V, Thakor P, Madan J, Singh P, Singh S . Fundamental Aspects of Lipid-Based Excipients in Lipid-Based Product Development. Pharmaceutics. 2022; 14(4). PMC: 9025782. DOI: 10.3390/pharmaceutics14040831. View

18.

Chang S, Lin H, Wu G, Tsai G . pH Effects on solubility, zeta potential, and correlation between antibacterial activity and molecular weight of chitosan. Carbohydr Polym. 2015; 134:74-81. DOI: 10.1016/j.carbpol.2015.07.072. View

19.

Kontomaris S, Stylianou A, Malamou A . Atomic Force Microscopy Nanoindentation Method on Collagen Fibrils. Materials (Basel). 2022; 15(7). PMC: 8999528. DOI: 10.3390/ma15072477. View

20.

Ferreira L, Dos Santos R, Oliva G, Andricopulo A . Molecular docking and structure-based drug design strategies. Molecules. 2015; 20(7):13384-421. PMC: 6332083. DOI: 10.3390/molecules200713384. View